FDA Grants Full Approval to KBro Vet CA-1 Chewable for Dogs with Idiopathic Epilepsy
Big news in veterinary neurology: the U.S. Food and Drug Administration (FDA) has granted full approval to KBroVet® (potassium bromide chewable tablets) for the control of seizures in dogs diagnosed with idiopathic epilepsy. This makes it the first FDA approved medication for idiopathic epilepsy in dogs.
FDA Grants Full Approval of a Drug to Control Seizures in Dogs with Idiopathic Epilepsy
The U.S. Food and Drug Administration has granted full approval to KBroVet (potassium bromide chewable tablets) for the control of seizures in dogs with idiopathic epilepsy, a type of seizure disorder without a known cause.
Zoetis launches digital resource center for poultry vaccine best practices
Zoetis is offering a new, comprehensive digital resource library designed to help poultry producers protect their vaccine investment through consistent, effective vaccine handling and administration.
CareVet Launches Clinical Outcomes Showcase to Elevate Real-World Outcomes Improving Patient Care
Veterinary medicine is evolving rapidly as case complexity increases and expectations from clients and care teams continue to rise. In response, CareVet today announced the launch of its CareVet Clinical Outcomes Showcase, a new initiative designed to elevate and share the real-world practices, ideas, and innovations improving patient care across veterinary medicine.
Purina Pro Plan Veterinary Partners with Veterinary Hope Foundation to Support Vet Mental Health
Veterinary professionals face immense emotional and mental demands every day, caring for both animals and their owners. To help address this burden, Purina Pro Plan Veterinary has partnered with the Veterinary Hope Foundation (Vet Hope) to expand access to structured mental health resources for veterinarians and their teams nationwide.
Penn Vet’s New Bolton Center to Add $94 Million State-of-the-Art Laboratory
The University of Pennsylvania School of Veterinary Medicine is expanding its New Bolton Center in Kennett Square with a $94 million laboratory addition, consolidating critical veterinary diagnostic and research services under one roof.